LONZA

Numerous corporate results and events are scheduled for 14 October: Lonza will report Q3 revenue, ASML and several US banks including Blackrock, Bank of America, Morgan Stanley and State Street will publish Q3 figures. There are also pre-close calls from Airbus and Schaeffler, plus other company and investor appointments. On the economic front, China's trade balance, US consumer prices and the Fed's Beige Book will be released; additionally, the Bundestag plans a government statement by Chancellor Friedrich Merz. » Altro su finanzen.net

Lonza and US company Asimov agree a strategic collaboration to advance production of lentiviral vectors for in‑vivo applications. Asimov contributes cell line technologies; Lonza provides process development, upscaling, analytics and GMP manufacturing. The aim is to develop stable production systems and to optimize genetic sequences and processes up to clinical and commercial production. Lonza shares rose briefly in SIX trading. » Altro su finanzen.net

Lonza is developing an aseptic spray drying process at its Bend (USA) site to enable high‑concentration formulations of biologics such as monoclonal antibodies, antibody‑drug conjugates (ADCs) and peptides. Initial tests showed various antibodies and ADCs can be reliably spray dried, with the aim of creating new solutions for high‑dose subcutaneous applications. The process is intended to improve stability and reduce viscosity but still faces technical hurdles such as protein stability, sterile processing, formulation optimization and scaling to industrial production. The Lonza share was at times 0.64% lower at 571.53 francs. » Altro su finanzen.net